MarketPeel
Insider Trading Intelligence
MM

Michael Mano

KPTI
SVP, GENERAL COUNSEL&SECRETARY · KARYOPHARM THERAPEUTICS INC. · CIK 0001837741
FILING MIX · LIFETIME63%/37%
BUYS
15
SELLS
9
TOTAL VALUE
$107.8K
COMPANIES
1
ACTIVE SINCE
Feb 2022
HOLDINGS NOW
94,398
AVG SELL PX
$2.56
TRADE KIND
SHOWING 24 / 24
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
8 backtested trades · 8 horizons · 7 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Michael Mano, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d8+37.50%+6.63%-0.30%+6.92%+1.06%
14d8+37.50%+3.75%-0.58%+4.33%+1.23%
30d8+50.00%+2.49%-0.21%+2.71%+7.43%
60d8+62.50%-0.13%+0.81%-0.94%-8.40%
90d8+75.00%-16.02%+4.35%-21.93%-22.20%
180d8(1 pending)+71.43%-16.82%+9.41%-26.23%-38.82%
1y8(2 pending)+83.33%-34.92%+21.87%-56.78%-71.70%
2y8(4 pending)+100.00%-59.99%+43.56%-103.55%-97.28%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
KPTI · 94,398 shares · as of May 14, 2026
074,600149,201223,801298,4012023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 15 buys / 9 sellsCOVERAGE · 18 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
KPTI
KARYOPHARM THERAPEUTICS INC.
SALE
EVP, CLO&Secretary
266$9.50$2.5K94,398May 14, 2026May 15, 2026View →
KPTI
KARYOPHARM THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
70094,664May 13, 2026May 15, 2026View →
KPTI
KARYOPHARM THERAPEUTICS INC.
SALE
EVP, CLO&Secretary
3,526$9.41$33.2K93,964Mar 2, 2026Mar 3, 2026View →
KPTI
KARYOPHARM THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
32,41597,490Jan 31, 2026Feb 3, 2026View →
KPTI
KARYOPHARM THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
43,65065,075Oct 15, 2025Oct 16, 2025View →
KPTI
KARYOPHARM THERAPEUTICS INC.
SALE
SVP, General Counsel&Secretary
234$6.43$1.5K21,425Sep 15, 2025Sep 16, 2025View →
KPTI
KARYOPHARM THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
61221,659Sep 12, 2025Sep 16, 2025View →
KPTI
KARYOPHARM THERAPEUTICS INC.
SALE
SVP, General Counsel&Secretary
2,793$6.29$17.6K21,047Mar 4, 2025Mar 6, 2025View →
KPTI
KARYOPHARM THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
3,33321,590Feb 28, 2025Mar 4, 2025View →
KPTI
KARYOPHARM THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
4,5004,500Feb 28, 2025Mar 4, 2025View →
KPTI
KARYOPHARM THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
2,25023,840Feb 28, 2025Mar 4, 2025View →
KPTI
KARYOPHARM THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
6,6666,666Feb 28, 2025Mar 4, 2025View →
KPTI
KARYOPHARM THERAPEUTICS INC.
SALE
SVP, General Counsel&Secretary
3,971$0.72$2.9K273,881Sep 4, 2024Sep 5, 2024View →
KPTI
KARYOPHARM THERAPEUTICS INC.
SALE
SVP, General Counsel&Secretary
3,576$1.20$4.3K277,852Mar 1, 2024Mar 4, 2024View →
KPTI
KARYOPHARM THERAPEUTICS INC.
SALE
SVP, General Counsel&Secretary
16,973$1.17$19.9K281,428Feb 29, 2024Mar 4, 2024View →
KPTI
KARYOPHARM THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
147,000298,401Feb 28, 2024Feb 29, 2024View →
KPTI
KARYOPHARM THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
9,167151,401Jan 24, 2024Jan 25, 2024View →
KPTI
KARYOPHARM THERAPEUTICS INC.
SALE
SVP, General Counsel&Secretary
3,888$1.33$5.2K142,234Sep 1, 2023Sep 5, 2023View →
KPTI
KARYOPHARM THERAPEUTICS INC.
SALE
SVP, General Counsel&Secretary
6,878$3.03$20.8K146,122Mar 1, 2023Mar 2, 2023View →
KPTI
KARYOPHARM THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
70,000153,000Feb 28, 2023Mar 2, 2023View →
KPTI
KARYOPHARM THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
20,00083,000Aug 31, 2022Sep 1, 2022View →
KPTI
KARYOPHARM THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
30,00030,000Aug 31, 2022Sep 1, 2022View →
KPTI
KARYOPHARM THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
81,00081,000Feb 28, 2022Mar 2, 2022View →
KPTI
KARYOPHARM THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
63,00063,000Feb 28, 2022Mar 2, 2022View →
Other insiders · KPTI
Loading peer insiders…
About this filer
CIK 0001837741
ROLE
SVP, General Counsel&Secretary
PRIMARY
KPTI
COMPANIES
1
ACTIVE SINCE
Feb 2022
MARKETPEEL · /INSIDER/0001837741DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback